Testosterone Science

Diabetes, Metabolic Health and Body Composition

Can GLP-1s Raise Testosterone? What Men Taking Ozempic, Wegovy or Zepbound Should Know

Specific Claim Evaluated

Some men with obesity and low testosterone may see testosterone improve on GLP-1 receptor agonists, mainly through weight and metabolic improvement rather than a direct effect, and weight loss is first-line for obesity-associated hypogonadism.

Primary Research Supporting or Contradicting the Claim

A meta-analysis of 7 studies found that GLP-1 receptor agonists increased total testosterone in overweight and obese men, with the increase correlated with weight loss, and that a direct testicular action could not be demonstrated (Salvio et al., 2025).

Corrected Evidence-Based Interpretation

The article is correct. Testosterone gains with GLP-1 receptor agonists are modest and do not replace diagnostic evaluation for hypogonadism.

Rationale for Grade

The article avoids describing the drugs as testosterone boosters, distinguishes GLP-1 therapy from testosterone replacement and notes possible lean mass loss. Its claims are consistent with meta-analytic evidence.

References

  1. Salvio G, Ciarloni A, Ambo N, Bordoni M, Perrone M, Rossi S, Balercia G. Effects of glucagon-like peptide 1 receptor agonists on testicular dysfunction: a systematic review and meta-analysis. Andrology. 2025;13(8):2022-2034. PMID
    Supporting excerpt: "The limitations of the current literature do not allow to demonstrate a direct action"

Post a Comment

Shared Decision Making

Bring the Evidence to Your Next Consultation

Use our patient resources and questionnaires to prepare questions about symptoms, testing and treatment options for your doctor.